OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.

Leprosy review

Volumn 83, Issue 3, 2012, Pages 261-268

  Cunha, Maria Da Graça Souza ^a   Virmond, Marcos ^b   Schettini, Antonio Pedro ^b   Cruz, Rossilene Conceição ^b   Ura, Somei ^b   Ghuidella, Cassio ^b   Viana, Francisco Dos Reis ^b   Avelleira, João Carlos Regazzi ^b   Campos, Antônio A Augusto ^b   Filho, Brasil ^b  

^a Fundação de Dermatologia Tropical e Venerologia Alfredo da Matta   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; LEPROSTATIC AGENT; OFLOXACIN; RIFAMPICIN;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; BRAZIL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MOUSE; MULTIBACILLARY LEPROSY; MULTICENTER STUDY; MYCOBACTERIUM LEPRAE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SKIN; TIME; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANIMALS; BRAZIL; CLOFAZIMINE; DAPSONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; LEPROSY, MULTIBACILLARY; MALE; MICE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; OFLOXACIN; PREVALENCE; RECURRENCE; RIFAMPIN; SKIN; TIME FACTORS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84873259024     PISSN: 03057518     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)